Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection in young children and older adults. Currently, no licensed vaccine is available, and therapeutic options are limited. The primary target of neutralizing antibodies to RSV is the surface fusion (F) glycoprotein....

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Xiao, Tang, Aimin, Cox, Kara S., Wen, Zhiyun, Callahan, Cheryl, Sullivan, Nicole L., Nahas, Deborah D., Cosmi, Scott, Galli, Jennifer D., Minnier, Michael, Verma, Deeptak, Babaoglu, Kerim, Su, Hua, Bett, Andrew J., Vora, Kalpit A., Chen, Zhifeng, Zhang, Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816417/
https://www.ncbi.nlm.nih.gov/pubmed/31402751
http://dx.doi.org/10.1080/19420862.2019.1654304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816417/
https://www.ncbi.nlm.nih.gov/pubmed/31402751
http://dx.doi.org/10.1080/19420862.2019.1654304

Ejemplares similares